Doug Baumann

Research & Development
Doug Baumann

Doug’s Ph.D. research, performed at Penn State, elucidated basic mechanisms of transcription regulation.

During his postdoctoral research at both the Universities of Michigan and Virginia, he utilized highly multiplexed, high content imaging coupled with systems biology approaches to understand transcription networks that underpin chemotherapy resistance in cancer.

At Dewpoint, he is working to discover new small molecules in oncology by employing image-based phenotypic screens that are guided by our expertise in condensate biology.

Dewpoint Therapeutics
451 D Street, Suite 104
Boston, MA 02210
USA
© 2019-2024 - Dewpoint Therapeutics

Design: SALIENCE Communication / Publiepress
Scientific animation: Visual Science